Press Releases

  • May 5, 2021

    Nemaura Medical Announces Order for 200,000 sugarBEAT® Sensors

    Based on the success of the soft launch in the U.K., the Company is advancing discussions for joint launches...

    April 29, 2021

    Nemaura Medical Issues Letter to Shareholders Following April 28 Shareholder Update Call

    Loughborough, England – April 29, 2021 (GlobeNewswire) – Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical...

    April 13, 2021

    Nemaura Medical Launches BEAT®diabetes Smartphone App on Android and iOS Platforms; Begins Pilot Distribution of proBEAT™ Sensors

    Loughborough, England – April 13, 2021 (GlobeNewswire) – Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical...

    March 25, 2021

    Nemaura Medical Retains Paul Kennedy as Advisor for International Growth Opportunities and Member of the Executive Advisory Board

    Loughborough, England – March 25, 2021 (GlobeNewswire)– Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic...

    March 11, 2021

    Nemaura Medical Announces Submission to German Authorities for Reimbursement of its Glucose Monitoring Device

    Loughborough, England, March 11, 2021 (GLOBE NEWSWIRE) — Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical...

    March 10, 2021

    Nemaura Medical to Present at Maxim Group’s Inaugural Emerging Growth Virtual Conference

    Loughborough, England, March 10, 2021 (GLOBE NEWSWIRE) — Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical...

    March 4, 2021

    Nemaura Medical Appoints Industry Veteran Alistair Longmuir as Advisor on Global Product Manufacture Strategy

    Loughborough, England, March 04, 2021 (GLOBE NEWSWIRE) — Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical...

    March 3, 2021

    Nemaura Medical to Present at the H.C. Wainwright Global Life Sciences Conference

    Loughborough, England – March 3, 2021 (GlobeNewswire) – Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical...

    February 5, 2021

    Nemaura Medical Appoints Thomas Mortensen as Head of E.U. Commercial Operations and Marketing

    Loughborough, England – February 4, 2021 (GlobeNewswire) – Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical...

    February 1, 2021

    Nemaura Medical Appoints Jay L. Warner as Head of U.S. Commercial Operations

    Loughborough, England – February 1, 2021 (GlobeNewswire) – Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical...